HomeCAPR • NASDAQ
add
Capricor Therapeutics Inc
Previous close
$28.67
Day range
$27.14 - $28.49
Year range
$4.30 - $40.37
Market cap
1.24B USD
Avg Volume
4.54M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.92M | 71.06% |
Net income | -24.57M | -95.68% |
Net profit margin | — | — |
Earnings per share | -0.54 | -42.11% |
EBITDA | -25.79M | -103.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 98.57M | 15.92% |
Total assets | 126.44M | 36.03% |
Total liabilities | 42.57M | 72.45% |
Total equity | 83.87M | — |
Shares outstanding | 45.72M | — |
Price to book | 15.67 | — |
Return on assets | -50.54% | — |
Return on capital | -64.29% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -24.57M | -95.68% |
Cash from operations | -19.69M | -69.11% |
Cash from investing | 15.95M | 695.70% |
Cash from financing | 6.95K | -99.99% |
Net change in cash | -3.73M | -106.47% |
Free cash flow | -16.52M | -127.44% |
About
CEO
Founded
2005
Website
Employees
160
